Artificial intelligence-guided radiation planning for glioblastoma
Part of Cancer clinical trials.
This study tests whether using artificial intelligence to plan radiation therapy can improve treatment for people with a newly diagnosed type of brain tumor called glioblastoma. If you qualify, you would receive radiation therapy planned with the help of a computer program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been recently diagnosed with a type of brain tumor called glioblastoma (grade 4).
- You need to be healthy enough to have MRI scans.
- You should be able to perform most daily activities on your own (score of at least 60 on a standard health scale).
- Your blood counts and liver/kidney function need to be within safe ranges (blood tests will be done).
- You must not have had prior radiation or chemotherapy for this tumor, nor any other cancer treatment in the last 3 years.
- You must not have a pacemaker, metal implants, or other conditions that make MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan radiation therapy for brain tumors (gliomas) using artificial intelligence. It aims to make treatment more precise and personalized for people with either aggressive (GBM) or slower-growing (IDH-mutant) gliomas.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This Phase 2 study tests a combination of chemotherapy and radiation after surgery for certain brain tumors that are “IDH wildtype.” It aims to control the tumor and improve outcomes for people with specific types of glioma or glioblastoma.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial is testing an escalated dose of proton beam radiation, along with standard chemotherapy and MRI-guided planning, for newly diagnosed glioblastoma. It aims to see whether the higher radiation dose can improve treatment while staying safe for nearby critical brain structures.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.